Enfusion Valuation
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
At this time, the firm appears to be overvalued. Enfusion shows a prevailing Real Value of $9.24 per share. The current price of the firm is $10.76. Our model computes the value of Enfusion from reviewing the firm fundamentals such as Current Valuation of 1.01 B, shares outstanding of 94.8 M, and Profit Margin of 0.01 % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Enfusion's price fluctuation is very steady at this time. Calculation of the real value of Enfusion is based on 3 months time horizon. Increasing Enfusion's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Enfusion is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enfusion Stock. However, Enfusion's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.76 | Real 9.24 | Hype 10.76 | Naive 10.79 |
The intrinsic value of Enfusion's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enfusion's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enfusion helps investors to forecast how Enfusion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enfusion more accurately as focusing exclusively on Enfusion's fundamentals will not take into account other important factors: About Enfusion Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Enfusion. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Enfusion based exclusively on its fundamental and basic technical indicators. By analyzing Enfusion's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Enfusion's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enfusion. We calculate exposure to Enfusion's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Enfusion's related companies.Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people.
Enfusion Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 129.6 M | |
| Quarterly Earnings Growth Y O Y | -0.818 | |
| Forward Price Earnings | 47.619 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |